
Insider and congress filings
Medtronic Plc (MDT)
NYSE · Healthcare · 356 insider transactions · 177 congress trades · last filed 5 days agoS&P 500
About Medtronic Plc
from the company's filings and listing, as of Oct 20, 2026- Exchange
- NYSE
- Sector
- Healthcare
- Industry
- Medical - Devices
- Chief executive
- Geoffrey Straub Martha
- Employees
- 95,000
- Listed since
- -
- Market value
- $118.7B
- Price to earnings (12 mo)
- 22.7
- Net income per share, as reported (12 mo)
- $4.09
- Dividend yield
- 3.08%
Company news
1 article · newest first| Headline | Source | Date |
|---|---|---|
| Medtronic presents registry results for Sphere-9 and PulseSelect at APHRS 2026The global analyses cover patients with atrial fibrillation and ventricular tachycardia, and Medtronic said the results were positive. | Company release | Oct 22, 2026 |
Written by GetSignal with AI from the company's own SEC filings and press releases; each article links to its source. Not investment advice. Company news from every company we cover
Earnings
6 reported quarters · next on Nov 17, 2026| Quarter | EPS | EPS expected | Revenue | Revenue expected | Result |
|---|---|---|---|---|---|
| Q1 FY2027reported Sep 1, 2026 | $1.45 | $1.39 | $9.8B | $9.5B | EPS beatRevenue beat |
| Q4 FY2026reported Jun 3, 2026 | $1.55 | $1.54 | $9.8B | $9.6B | EPS in lineRevenue beat |
| Q3 FY2026reported Feb 17, 2026 | $1.36 | $1.34 | $9.0B | $8.9B | EPS in lineRevenue in line |
| Q2 FY2026reported Nov 18, 2025 | $1.36 | $1.31 | $9.0B | $8.9B | EPS beatRevenue in line |
| Q1 FY2026reported Aug 19, 2025 | $1.26 | $1.23 | $8.6B | $8.4B | EPS beatRevenue beat |
| Q4 FY2025reported May 21, 2025 | $1.62 | $1.58 | $8.9B | $8.8B | EPS beatRevenue in line |
Actual against the consensus estimate at the time. A flag marks a beat or a miss of more than 1.5% either way; inside that band the quarter is in line. A flag reads n/a only when a number is missing. Quarterly EPS is the figure set against the consensus, usually adjusted, so the quarters need not add up to the 12-month net income per share above. An estimate is a forecast made by analysts, not a company target.
Executive pay
as filed for fiscal 2026 · proxy filed Aug 17, 2026| Executive | Salary | Stock awards | Other | Total |
|---|---|---|---|---|
| Geoff MarthaChairman and Chief Executive Officer | $1.4M | $13.7M | $7.9M | $22.9M |
| Thierry PiétonEVP, Chief Financial Officer | $850K | $3.2M | $4.6M | $8.6M |
| Mike MarinaroEVP & President Medical Surgical Portfolio & Americas | $820K | $3.6M | $2.4M | $6.8M |
| Michelle QuinnEVP, General Counsel and Secretary | $600K | $3.5M | $2.6M | $6.7M |
The summary compensation table from the proxy statement for fiscal 2026, with titles as filed then. 1 executive who has since left the company is named in that filing and not shown here. Read the filing
Institutional holders
13F positions as of Jun 30, 2026| Holder | Value | Shares | Shares vs prior qtr | % of shares out |
|---|---|---|---|---|
| BlackRock, Inc. | $8.9B | 114,020,787 | +0.7% | 8.91% |
| Vanguard Capital Management LLC | $6.6B | 83,816,735 | +0.6% | 6.55% |
| State Street Corp | $5.0B | 63,399,315 | +2.7% | 4.95% |
| Vanguard Portfolio Management LLC | $2.7B | 34,059,967 | +1.8% | 2.66% |
| Massachusetts Financial Services Co | $2.6B | 19,872,600 | -7.3% | 1.55% |
| Geode Capital Management, LLC | $2.4B | 30,192,015 | +5.1% | 2.36% |
| JPMorgan Chase & Co. | $2.2B | 27,784,471 | -45.5% | 2.17% |
| Bank of America Corp | $1.7B | 21,322,401 | -18.0% | 1.67% |
| Morgan Stanley | $1.5B | 19,444,871 | -6.1% | 1.52% |
| Deutsche Bank AG | $1.4B | 18,449,877 | -2.9% | 1.44% |
| Invesco Ltd. | $1.4B | 17,885,150 | +6.5% | 1.40% |
| Franklin Templeton Inc | $1.4B | 17,550,983 | +23.8% | 1.37% |
A 13F reports long US equity positions and is filed within 45 days of the quarter end, so these are positions as they stood on Jun 30, 2026. For a manager's whole book see the fund directory. What a 13F covers and leaves out is explained in our guide to Form 13F.
Tracked fund managers holding MDT
2 managers| Manager | Value | Shares | Share of book |
|---|---|---|---|
| Renaissance TechnologiesJim Simons | $247.8M | 3,167,741 | 0.3% |
| Trexquant Investment | $88.6M | 1,132,741 | 0.5% |
2 of the 97 fund managers we track list MDT shares among the largest positions in their latest 13F, filed for Q2 2026. A manager can hold it further down the book too, so this is a floor, not a count. Share of book is the position against the manager's whole disclosed 13F value.
Open-market insider trades
5 filings shown · newest filing first| Insider | Action | Shares | Price | Value | Trade date | Delay (business days) |
|---|---|---|---|---|---|---|
| Geoffrey MarthaChairman and CEO | Sold · scheduled | 50,000 | $95.00 | $4.8M | Oct 15, 2026filed Oct 16, 2026 | 1d |
| Michael MarinaroEVP, Pres Medsurg and Americas | Sold · scheduled | 10,420 | $96.00 | $1.0M | Oct 15, 2026filed Oct 16, 2026 | 1d |
| Harry Skip KiilEVP & President Cardiovascular | Sold | 1,483 | $93.65 | $139K | Sep 16, 2026filed Sep 17, 2026 | 1d |
| Matthew R. WalterSVP, Chief HR Officer | Sold · scheduled | 3,102 | $83.15 | $258K | Jul 8, 2026filed Jul 9, 2026 | 1d |
| Harry Skip KiilEVP & President Cardiovascular | Sold · 2 lines | 4,189 | $80.44 | $337K | Jun 8, 2026filed Jun 9, 2026 | 1d |
One row is one filing, newest filing first. A filing that reported its trade in several tranches is summed, priced at the weighted average, and marked with its line count. Scheduled: set up in advance under a Rule 10b5-1 trading plan. The delay counts business days from the trade to the filing, the unit of Form 4's two business day deadline: weekends and federal holidays are skipped. How the filing itself works is explained in our guide to Form 4.
Other Form 4 activity (20)
| Insider | Event | Shares | Date |
|---|---|---|---|
| Kevin E. LoftonDirector | Other (see filing) | 182 | Oct 15, 2026 |
| Denise L. BlomquistChief Accounting Officer | Gift | 600 | Sep 15, 2026 |
| Michael MarinaroEVP, Pres Medsurg and Americas | Tax withholding | 1,084 | Aug 20, 2026 |
| Matthew R. WalterSVP, Chief HR Officer | Stock award | 61,163 | Aug 3, 2026 |
| Matthew R. WalterSVP, Chief HR Officer | Tax withholding | 1,675 | Jul 31, 2026 |
| Denise L. BlomquistChief Accounting Officer | Stock award | 3,703 | Aug 3, 2026 |
| Denise L. BlomquistChief Accounting Officer | Tax withholding | 212 | Jul 31, 2026 |
| Geoffrey MarthaChairman and CEO | Stock award | 713,516 | Aug 3, 2026 |
| Geoffrey MarthaChairman and CEO | Tax withholding | 15,810 | Jul 31, 2026 |
| Harry Skip KiilEVP & President Cardiovascular | Stock award | 97,860 | Aug 3, 2026 |
| Harry Skip KiilEVP & President Cardiovascular | Tax withholding | 3,074 | Jul 31, 2026 |
| Michael MarinaroEVP, Pres Medsurg and Americas | Stock award | 162,355 | Aug 3, 2026 |
| Michael MarinaroEVP, Pres Medsurg and Americas | Tax withholding | 3,356 | Jul 31, 2026 |
| Thierry PietonEVP & Chief Financial Officer | Stock award | 122,324 | Aug 3, 2026 |
| Michelle QuinnEVP, GC and Secretary | Stock award | 67,279 | Aug 3, 2026 |
| Kweli ThompsonEVP & President, Neuroscience | Stock award | 73,396 | Aug 3, 2026 |
| Kweli ThompsonEVP & President, Neuroscience | Tax withholding | 1,739 | Jul 31, 2026 |
| Michelle QuinnEVP, GC and Secretary | Tax withholding | 2,069 | Jul 28, 2026 |
| Kweli ThompsonEVP & President, Neuroscience | Other Form 4 entry (see filing) | 22,363 | Jul 28, 2026 |
| Kweli ThompsonEVP & President, Neuroscience | Other Form 4 entry (see filing) | 1,540 | Jul 29, 2025 |
Awards, option exercises, shares withheld to cover tax and gifts all file on the same form as a purchase or a sale. None of them is a decision to trade, so they sit here rather than beside the ones that are.
Congress trades in MDT
20 disclosures of 177 on record · median 25d of the 45 allowedSince the trade: the stock's move from the trade date to the latest close we hold (figures as of Oct 25, 2026), not the member's result. Not investment advice.
| Member | Type | Action | Amount disclosed | Stock since the trade | Trade date | Disclosed | Delay |
|---|---|---|---|---|---|---|---|
| Kevin HernJoint | Stock | Sale | $15,001 - $50,000 | +2.7%After the saleS&P 500 -0.5% · +3.2 pts vs S&P 500 | Aug 24, 2026 | Sep 1, 2026 | 8d |
| Richard McCormick | Stock | Sale | $1,001 - $15,000 | +11.3%After the saleS&P 500 +2.5% · +8.9 pts vs S&P 500 | Jul 30, 2026 | Aug 14, 2026 | 15d |
| Julie JohnsonJointFiled late | Stock | Sale | $1,001 - $15,000 | +14.7%After the saleS&P 500 +35.4% · -20.7 pts vs S&P 500 | May 7, 2025 | Aug 5, 2026 | 455d |
| Alan ArmstrongSelf | Stock | Purchase | $1,001 - $15,000 | +9.5%S&P 500 +19.8% · -10.3 pts vs S&P 500 | Mar 27, 2026 | Jul 21, 2026 | 116d |
| Ro Khanna | Stock | Purchase | $1,001 - $15,000 | +25.3%S&P 500 +2.8% · +22.5 pts vs S&P 500 | May 15, 2026 | Jun 9, 2026 | 25d |
| Ro Khanna | Stock | Purchase | $1,001 - $15,000 | +25.6%S&P 500 +1.3% · +24.3 pts vs S&P 500 | May 27, 2026 | Jun 9, 2026 | 13d |
| Gilbert Ray Cisneros, Jr. | Stock | Sale | $1,001 - $15,000 | +25.3%After the saleS&P 500 +2.8% · +22.5 pts vs S&P 500 | May 15, 2026 | Jun 8, 2026 | 24d |
| Ro Khanna | Stock | Sale | $15,001 - $50,000 | +6.1%After the saleS&P 500 +12.2% · -6.0 pts vs S&P 500 | Mar 10, 2026 | Apr 7, 2026 | 28d |
| Ro Khanna | Stock | Sale | $1,001 - $15,000 | +9.5%After the saleS&P 500 +15.6% · -6.1 pts vs S&P 500 | Mar 23, 2026 | Apr 7, 2026 | 15d |
| Ro Khanna | Stock | Sale | $1,001 - $15,000 | +11.3%After the saleS&P 500 +20.3% · -9.0 pts vs S&P 500 | Mar 30, 2026 | Apr 7, 2026 | 8d |
| Kevin HernJoint | Stock | Sale | $15,001 - $50,000 | +10.7%After the saleS&P 500 +16.8% · -6.1 pts vs S&P 500 | Mar 20, 2026 | Apr 3, 2026 | 14d |
| Ro Khanna | Stock | Purchase | $1,001 - $15,000 | -5.4%S&P 500 +10.2% · -15.6 pts vs S&P 500 | Jan 23, 2026 | Feb 6, 2026 | 14d |
| Ro Khanna | Stock | Sale | $1,001 - $15,000 | -5.8%After the saleS&P 500 +10.3% · -16.1 pts vs S&P 500 | Jan 22, 2026 | Feb 6, 2026 | 15d |
| Julie JohnsonJoint | Stock | Sale | $1,001 - $15,000 | -3.1%After the saleS&P 500 +12.3% · -15.4 pts vs S&P 500 | Dec 18, 2025 | Jan 15, 2026 | 28d |
| Julie JohnsonJoint | Stock | Sale | $1,001 - $15,000 | -0.8%After the saleS&P 500 +13.0% · -13.8 pts vs S&P 500 | Nov 13, 2025 | Dec 11, 2025 | 28d |
| Richard McCormick | Stock | Purchase | $1,001 - $15,000 | +5.5%S&P 500 +12.2% · -6.6 pts vs S&P 500 | Nov 5, 2025 | Dec 9, 2025 | 34d |
| Richard McCormick | Stock | Purchase | $1,001 - $15,000 | +21.7%S&P 500 +95.3% · -73.6 pts vs S&P 500 | Mar 15, 2023 | Sep 17, 2025 | 917d |
| Julie JohnsonJoint | Stock | Sale | $1,001 - $15,000 | +3.7%After the saleS&P 500 +17.8% · -14.1 pts vs S&P 500 | Aug 14, 2025 | Sep 11, 2025 | 28d |
| Ro Khanna | Stock | Purchase | $1,001 - $15,000 | +6.4%S&P 500 +20.4% · -14.0 pts vs S&P 500 | Aug 4, 2025 | Sep 9, 2025 | 36d |
| Ro Khanna | Stock | Sale | $1,001 - $15,000 | +10.9%After the saleS&P 500 +23.2% · -12.3 pts vs S&P 500 | Jun 27, 2025 | Jul 9, 2025 | 12d |
Since the trade is an estimate, set beside the S&P 500 over the same window, with the gap between the two in percentage points. The filing carries a band, not a fill, and a sale keeps the stock's sign, so a positive figure after a sale means the stock kept rising after it. An option row carries the underlying stock's move. A row marked n/a is one we hold no figure for.
A delay above 45 days is the gap between the dates on the report; we mark a filing late only after checking it.
"Not captured" means the band or the transaction type on the original report is missing from our data.
"Dates conflict" marks a row whose disclosure is dated before its trade on the record we hold. Both dates are printed as filed, and no since-the-trade figure is computed from them.
Every Congress trade in MDT, filterable by party, chamber, type and account.
Members of Congress reporting a position
15 members · estimate, as of Oct 19, 202615 members report a position (estimated). The largest estimated position is in the $15,001 - $50,000 band.
| Member | Party, chamber | Estimated position | Share of their portfolio |
|---|---|---|---|
| Gary C. Peters | Democrat · Senate | $15,001 - $50,000 | 1.0% |
| Robert Bresnahan | Republican · House | $15,001 - $50,000 | 0.2% |
| Debbie Dingell | Democrat · House | $15,001 - $50,000 | 0.4% |
| Gilbert Ray Cisneros, Jr. | Democrat · House | $15,001 - $50,000 | 0.1% |
| Harriet M. Hageman | Republican · House | $15,001 - $50,000 | 0.5% |
| Daniel Meuser | Republican · House | $15,001 - $50,000 | 0.6% |
| George Whitesides | Democrat · House | $1,001 - $15,000 | 0.1% |
| Shelley Moore Capito | Republican · Senate | $1,001 - $15,000 | 0.4% |
| Ron Wyden | Democrat · Senate | $1,001 - $15,000 | 0.1% |
| Cliff Bentz | Republican · House | $1,001 - $15,000 | 0.5% |
| Robert B. Aderholt | Republican · House | $1,001 - $15,000 | 1.0% |
| James Comer | Republican · House | $1,001 - $15,000 | 1.7% |
| Lucy McBath | Democrat · House | $1,001 - $15,000 | 0.1% |
| Robert Onder | Republican · House | $1,001 - $15,000 | 0.2% |
| Richard McCormick | Republican · House | $1,001 - $15,000 | 2.2% |
Estimate, as of Oct 19, 2026. Each position is modelled from the member's disclosed transactions and annual filings: the midpoint of each disclosed band, moved with the stock's price since the trade. It is a rough estimate of a reported position, not a figure from a filing, which is why it is shown as a band. Share of portfolio sets that estimate against the member's whole estimated public-stock portfolio.
Questions
Are insiders buying or selling MDT?
Across the 5 most recent open-market filings shown here, 0 were purchases and 5 were sales. 3 were scheduled in advance under a Rule 10b5-1 plan.
Which members of Congress have traded MDT?
Kevin Hern, Richard McCormick, Julie Johnson, Alan Armstrong, Ro Khanna and Gilbert Ray Cisneros, Jr. disclosed MDT transactions in the filings shown here.
Which members of Congress hold MDT?
15 members of Congress report a position in MDT in the estimate we hold as of Oct 19, 2026. The largest estimated positions, in the $15,001 - $50,000 band, include Gary C. Peters, Robert Bresnahan and Debbie Dingell. The estimate is built from disclosed transactions and annual filings, so it is shown as a band rather than a figure from a filing.
Is MDT in the S&P 500 or the Nasdaq 100?
Medtronic Plc is a current member of the S&P 500, per the membership list we hold as of Oct 26, 2026. Current members of either index get a page here whatever their filing history.
How quickly are MDT trades disclosed?
Insider filings on this page reached the public a median of 1 business day after the transaction (weekends and federal holidays skipped), against the two business days Form 4 allows. Congressional disclosures took a median of 25 days, against the 45 the STOCK Act allows.
How to read a Form 4
A DECISION THE INSIDER MADE
COMPENSATION PLUMBING
Congress rows disclose a value range rather than an exact amount, and the STOCK Act allows up to 45 days to report. Full sourcing and the limits of this data are on the methodology page. A filing is a record of a transaction, not a signal, and nothing here is investment advice.
Data as of Oct 26, 2026.
